| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044744595 |
| P356 | DOI | 10.1023/A:1022318921994 |
| P698 | PubMed publication ID | 12691498 |
| P2093 | author name string | Konstantine K. Zakzanis | |
| Zachariah Campbell | |||
| Simon J. Graham | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study | Q49103604 | ||
| Alzheimer's disease: longitudinal CT studies of ventricular change. | Q50559790 | ||
| Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer type. | Q50596160 | ||
| Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. | Q50596312 | ||
| Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. | Q51035072 | ||
| Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. | Q51046495 | ||
| Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease. | Q51048757 | ||
| Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. | Q52014724 | ||
| Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type | Q52041376 | ||
| Implicit verbal memory in Alzheimer's disease. | Q52056947 | ||
| Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. | Q52058102 | ||
| Differentiation of dementia and depression by memory tests. A meta-analysis. | Q52059257 | ||
| Structural brain CT changes and cognitive deficits in elderly depressives with and without reversible dementia ('pseudodementia'). | Q52064705 | ||
| Predominant left hemisphere metabolic dysfunction in dementia. | Q52117497 | ||
| Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. | Q52120461 | ||
| The effect of focal cerebral atrophy in positron emission tomographic studies of aging and dementia. | Q53184180 | ||
| In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. | Q53189485 | ||
| Use of computerized CT analysis to discriminate between Alzheimer patients and normal control subjects. | Q53191518 | ||
| Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. | Q53193402 | ||
| Cerebral blood flow in severity-matched Alzheimer and multi-infarct patients. | Q53195034 | ||
| HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. | Q53203336 | ||
| High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET. | Q53208290 | ||
| Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. | Q53208976 | ||
| Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. | Q53208979 | ||
| Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. | Q53211896 | ||
| Magnetic resonance imaging in Alzheimer's disease, multi-infarct dementia, alcoholic dementia and Korsakoff's psychosis. | Q53300871 | ||
| Cerebral perfusion as a diagnostic marker of early Alzheimer's disease | Q53304919 | ||
| Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. | Q53314070 | ||
| Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. | Q53317217 | ||
| Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. | Q53320601 | ||
| Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. | Q53324743 | ||
| Temporal lobe atrophy in patients with Alzheimer disease: a CT study. | Q64983913 | ||
| Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type | Q68093532 | ||
| CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease--initial results | Q68100078 | ||
| Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging | Q69754446 | ||
| 99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type--a study under clinical routine conditions | Q70946807 | ||
| Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia | Q71636601 | ||
| PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain | Q72354252 | ||
| Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity | Q72734958 | ||
| What is cognitive reserve? Theory and research application of the reserve concept | Q28213550 | ||
| (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type | Q30495819 | ||
| Changes in memory processing with age. | Q30588917 | ||
| Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis | Q32109009 | ||
| Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease | Q33591546 | ||
| Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study | Q33732188 | ||
| Specificity of changes in cerebral blood flow in patients with frontal lobe dementia | Q33732739 | ||
| Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter | Q33734929 | ||
| SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele | Q33735332 | ||
| Brain atrophy in frontotemporal dementia | Q33735444 | ||
| Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? | Q33827598 | ||
| Natural history of Alzheimer's disease. | Q34301522 | ||
| Cerebral blood flow and metabolic abnormalities in Alzheimer's disease | Q34305448 | ||
| A meta-analysis of the effects of cognitive therapy in depressed patients | Q34466938 | ||
| Statistics to tell the truth, the whole truth, and nothing but the truth Formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers | Q35573061 | ||
| Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study | Q36316973 | ||
| Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism | Q36318321 | ||
| Imaging the head: functional imaging | Q36718204 | ||
| The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. | Q36738408 | ||
| Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators | Q36774004 | ||
| Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data | Q36780987 | ||
| Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease | Q37314982 | ||
| Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease | Q37402317 | ||
| Advances in medical imaging for cancer diagnosis and treatment | Q37632618 | ||
| Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type | Q38461160 | ||
| SPECT perfusion imaging in the diagnosis of dementia. | Q40455499 | ||
| The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis | Q40808894 | ||
| Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease | Q40909045 | ||
| Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease | Q41096506 | ||
| Sylvian fissure size in schizophrenia measured with the magnetic resonance imaging rating protocol of the Consortium to Establish a Registry for Alzheimer's Disease | Q41108581 | ||
| Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type. | Q41213028 | ||
| The investigation of Alzheimer's disease with single photon emission tomography | Q41786659 | ||
| Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging | Q41788729 | ||
| Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism | Q42147259 | ||
| Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography | Q42283952 | ||
| Frequency of stages of Alzheimer-related lesions in different age categories | Q42445469 | ||
| Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease | Q42458585 | ||
| Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose | Q43509871 | ||
| Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease | Q43636750 | ||
| In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease | Q43684436 | ||
| Use of [11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. | Q43790805 | ||
| Regional cerebral glucose transport and utilization in Alzheimer's disease | Q44301133 | ||
| Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer's type | Q44475407 | ||
| Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type | Q44534844 | ||
| Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications | Q44580118 | ||
| Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type | Q44601832 | ||
| Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease | Q45029106 | ||
| Positron emission tomographic (PET) studies in dementia | Q45291033 | ||
| High-resolution PET studies in Alzheimer's disease | Q45738975 | ||
| Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. | Q46001832 | ||
| Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study. | Q46003977 | ||
| Cognitive therapy for psychosis in schizophrenia: an effect size analysis | Q47214454 | ||
| Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity | Q48094264 | ||
| Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia | Q48110604 | ||
| Organic factors and the clinical features of late paranoid psychosis: a comparison with Alzheimer's disease and normal ageing | Q48129871 | ||
| Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. | Q48130921 | ||
| Depression, cerebral atrophy, cognitive performance and incidence of dementia. Population study of 85-year-olds | Q48135608 | ||
| In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. | Q48149774 | ||
| Altered cerebral energy metabolism in Alzheimer's disease: a PET study. | Q48197690 | ||
| Evidence for atrophy of the corpus callosum in Alzheimer's disease | Q48202387 | ||
| Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT. | Q48210325 | ||
| A single photon emission computerised tomography study of regional brain function underlying verbal memory in patients with Alzheimer-type dementia | Q48244851 | ||
| A single photon emission computerised tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementia. | Q48244867 | ||
| Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease | Q48246685 | ||
| Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease | Q48285881 | ||
| Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease | Q48298121 | ||
| A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease. | Q48309151 | ||
| Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease | Q48311909 | ||
| Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease | Q48323726 | ||
| Brain is related to behavior (p<.05). | Q48332890 | ||
| Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease | Q48349386 | ||
| Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects | Q48355811 | ||
| Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia | Q48356923 | ||
| Quantitative analysis of T2 signal intensities in Alzheimer's disease | Q48386171 | ||
| Quantitative EEG mapping and PET in Alzheimer's disease | Q48460927 | ||
| Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease | Q48485192 | ||
| Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle:brain ratio (VBR) | Q48486832 | ||
| Comparative analysis of computed tomographic and magnetic resonance imaging scans in Alzheimer patients and controls | Q48497634 | ||
| Positron Emission Tomography and Familial Alzheimer's Disease: A Pilot Study | Q48529173 | ||
| Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography | Q48555922 | ||
| Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). | Q48556572 | ||
| Quantitative MR volumetry in Alzheimer's disease. Topographic markers and the effects of sex and education | Q48577035 | ||
| Computerised tomography in Alzheimer's disease. Methods of scan analysis, comparison with normal controls, and clinical/radiological associations | Q48633206 | ||
| The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease | Q48644193 | ||
| Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia | Q48705993 | ||
| Quantitative MRI volume changes in late onset schizophrenia and Alzheimer's disease compared to normal controls | Q48802172 | ||
| A quantitative analysis of CT and cognitive measures in normal aging and Alzheimer's disease | Q48849879 | ||
| Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. | Q48911306 | ||
| Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging | Q48958246 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuroimaging | Q551875 |
| meta-analysis | Q815382 | ||
| dementia | Q83030 | ||
| Alzheimer's disease | Q11081 | ||
| single-photon emission computed tomography | Q849737 | ||
| emission computed tomography | Q5372630 | ||
| functional brain imaging | Q130273132 | ||
| P304 | page(s) | 1-18 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Neuropsychology Review | Q7002594 |
| P1476 | title | A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile | |
| P478 | volume | 13 |
| Q36550955 | A comprehensive testing protocol for MRI neuroanatomical segmentation techniques: Evaluation of a novel lateral ventricle segmentation method |
| Q34021511 | Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability |
| Q48464443 | CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly |
| Q30953185 | CSF biomarkers for mild cognitive impairment |
| Q44894391 | Cholinergic enhancement of frontal lobe activity in mild cognitive impairment |
| Q37379402 | Distinct genetic influences on cortical surface area and cortical thickness |
| Q42010443 | Emotional memory in patients with Alzheimer's disease: a report of two cases |
| Q30718696 | Evaluating the consistency and specificity of neuroimaging data using meta-analysis |
| Q33624213 | Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria. |
| Q26852526 | Heart failure and Alzheimer's disease |
| Q33306779 | Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease |
| Q35124823 | Memory for emotional pictures in patients with Alzheimer's dementia: comparing picture-location binding and subsequent recognition |
| Q36360825 | Meta-analysis in neuropsychology: basic approaches, findings, and applications |
| Q48422478 | Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease |
| Q29041264 | Meta-analysis of functional neuroimaging data: current and future directions |
| Q22251259 | Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients |
| Q64446743 | Neuroimaging in Dementia |
| Q36926723 | Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland. |
| Q36169698 | Neuropsychological studies of mild traumatic brain injury: a meta-analytic review of research since 1995. |
| Q37924516 | Nuclear medicine imaging in dementia: a practical overview for hospitalists |
| Q36582762 | Regional cerebral blood flow reductions, heart failure and Alzheimer's disease. |
| Q91482742 | Replicable brain signatures of emotional bias and memory based on diffusion kurtosis imaging of white matter tracts |
| Q43444955 | Symptom validity testing in memory clinics: Hippocampal-memory associations and relevance for diagnosing mild cognitive impairment. |
| Q31105327 | The application of positron-emitting molecular imaging tracers in Alzheimer's disease |
| Q43850053 | Traumatic brain injury among Indiana state prisoners |
| Q36494813 | Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease |
| Q35237938 | Voxel-based meta-analysis of grey matter changes in Alzheimer's disease |
| Q42224781 | Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse |
| Q53512466 | [Neurodegenerative diseases]. |
Search more.